Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatorenal syndrome.

K D Biswas1, A K Jain

  • 1Department of Gastroenterology, Institute of Medical Sciences, Banaras Hindu University, Varanasi-221 005.

Tropical Gastroenterology : Official Journal of the Digestive Diseases Foundation
|April 16, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Profiling CARD14 gene expression in Indian Psoriasis patients.

Scientific reports·2024
Same author

Exploring the diversity of virulence genes in the <i>Magnaporthe</i> population infecting millets and rice in India.

Frontiers in plant science·2023
Same author

The Implementation of a Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) Program at a Level 1 New England Trauma Center: Feasibility and Early Outcomes.

The American surgeon·2023
Same author

Added value of the measles-rubella supplementary immunization activity in reaching unvaccinated and under-vaccinated children, a cross-sectional study in five Indian districts, 2018-20.

Vaccine·2022
Same author

Deep learning model for predicting tunnel damages and track serviceability under seismic environment.

Modeling earth systems and environment·2022
Same author

Role of GeneXpertMTB/RIF in the diagnosis of cutaneous tuberculosis.

The Indian journal of tuberculosis·2022

Hepatorenal syndrome, a severe liver complication, involves kidney dysfunction due to liver disease. Management focuses on improving renal circulation through vasoconstrictors and supportive therapies.

Area of Science:

  • Hepatology
  • Nephrology
  • Critical Care Medicine

Background:

  • Hepatorenal syndrome (HRS) is a serious complication of advanced liver disease, particularly cirrhosis.
  • It presents as kidney dysfunction in patients with liver failure, often triggered by factors like infection or dehydration.
  • Two main types exist: Type I (rapidly progressive, poor prognosis) and Type II (slowly progressive, better prognosis).

Purpose of the Study:

  • To elucidate the pathophysiology of hepatorenal syndrome.
  • To outline diagnostic criteria for accurate identification.
  • To review current and emerging management strategies.

Main Methods:

  • Review of existing literature on hepatorenal syndrome.
  • Analysis of pathophysiologic mechanisms, including peripheral vasodilation and intrarenal vasoconstriction.

Related Experiment Videos

  • Evaluation of diagnostic criteria established by the International Ascites Club.
  • Assessment of pharmacologic treatments and supportive measures.

    • Main Results:

    • Peripheral vasodilation and intrarenal vasoconstriction are key pathophysiologic changes.
    • International Ascites Club criteria aid in diagnosis.
    • Pharmacologic agents like vasopressin analogs aim to improve renal perfusion.
    • Liver transplantation remains a definitive treatment option.

    Conclusions:

    • Hepatorenal syndrome requires prompt diagnosis and management to improve patient outcomes.
    • Pharmacologic therapies serve as bridges to liver transplantation or hepatic function improvement.
    • Emerging treatments like MARS and TIPS offer additional therapeutic avenues.